• Measure Summary
  • NQMC:011141
  • 2015 Mar

Hepatopancreatobiliary (HPB) cancer: proportion of patients with hepatocellular carcinoma (HCC) undergoing disease specific treatment (liver transplant, resection, ablation, trans-arterial chemoembolisation [TACE] or systemic anti-cancer therapy [SACT]) who die within 30 days of definitive treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:010053
  • 2015 Oct
  • NQF-Endorsed Measure

Ambulatory surgery: percentage of Ambulatory Surgery Center (ASC) admissions experiencing a wrong site, wrong side, wrong patient, wrong procedure, or wrong implant.

Ambulatory Surgery Center (ASC) Quality Collaboration

  • Measure Summary
  • NQMC:011124
  • 2016 May

Sarcoma: proportion of patients with sarcoma who undergo surgical resection or oncological treatment with curative intent who die within 30 days of treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:011171
  • 2015 Jan

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who receive curative oncological treatment who die within 30 days of treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:009489
  • 2014 Jan

End stage renal disease (ESRD): percentage of Medicare patients with a mean hemoglobin value greater than 12 g/dL.

Centers for Medicare & Medicaid Services

  • Measure Summary
  • NQMC:008432
  • 2012 Sep

Non-OR procedural safety: percentage of wrong invasive or high-risk procedure events outside of the operating room per month.

Institute for Clinical Systems Improvement

  • Measure Summary
  • NQMC:011279
  • 2015 Jan

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo surgical resection in which longitudinal surgical margin is clear of tumour (i.e., negative surgical margin).

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:007457
  • 2011 Aug
  • NQF-Endorsed Measure

Pediatric kidney disease: percentage of calendar months within a 12-month period during which patients aged 17 years and younger with a diagnosis of ESRD receiving hemodialysis or peritoneal dialysis have a hemoglobin level less than 10 g/dL.

American Society of Pediatric Nephrology; Physician Consortium for Performance Improvement®; Renal Physicians Association

  • Measure Summary
  • NQMC:011007
  • 2017 Jan

Intra-procedure colonoscopy complication rate: percentage of patients who developed one or more intra-procedure colonoscopy complications.

AAAHC Institute for Quality Improvement, Performance Measurement Initiative, Colonoscopy Work Group

  • Measure Summary
  • NQMC:009661
  • 2014 Mar

Perioperative protocol: percentage of preoperative wound infections by wound classifications: Class I: clean, Class II: clean contaminated, and Class III: contaminated.

Institute for Clinical Systems Improvement

  • Measure Summary
  • NQMC:010870
  • 2015 Sep
  • NQF-Endorsed Measure

End stage renal disease (ESRD): percentage of all patient months for adult patients (≥ 18) whose delivered peritoneal dialysis dose was a weekly Kt/Vurea ≥ 1.7 (dialytic + residual).

Centers for Medicare & Medicaid Services

  • Measure Summary
  • NQMC:010241
  • 2015 Mar

Diagnostic imaging: percentage of CT exams with contrast performed that resulted in extravasation.

American College of Radiology

  • Measure Summary
  • NQMC:011243
  • 2017 Feb

Lung cancer: proportion of patients with lung cancer who receive treatment with curative intent (surgery, radical radiotherapy or chemoradiotherapy) who die within 90 days of treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:010424
  • 2015 Aug
  • NQF-Endorsed Measure

Eye care: percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and had any of a specified list of surgical procedures in the 30 days following cataract surgery which would indicate the occurrence of any of the following major complications: retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence.

American Academy of Ophthalmology; Physician Consortium for Performance Improvement®

  • Measure Summary
  • NQMC:011205
  • 2016 Jul

Prostate cancer: proportion of patients with prostate cancer undergoing radical prostatectomy with post surgical incontinence (greater than 0 pads per day measured using a validated tool) at 1 year (10 to 14 months) post radical prostatectomy.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:011172
  • 2015 Jan

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who receive palliative oncological treatment who die within 30 days of treatment.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:011166
  • 2015 Jan

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who die within 30 or 90 days of surgical resection for oesophageal or gastric cancer.

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:011169
  • 2015 Jan

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo surgical resection in which circumferential and longitudinal surgical margin is clear of tumour (i.e., negative surgical margin).

NHS Scotland; Scottish Cancer Taskforce

  • Measure Summary
  • NQMC:010048
  • 2015 Oct

Ambulatory surgery: percentage of patients having surgical procedures under general or neuraxial anesthesia of 60 minutes or more in duration who are normothermic within 15 minutes of arrival in the post-anesthesia care unit (PACU).

Ambulatory Surgery Center (ASC) Quality Collaboration

  • Measure Summary
  • NQMC:011159
  • 2016 Jun

Testicular cancer: proportion of patients with testicular cancer who die within 30 days of treatment for testicular cancer.

NHS Scotland; Scottish Cancer Taskforce